Galectin-1 is essential for the induction of MOG35–55-based intravenous tolerance in experimental autoimmune encephalomyelitis

European Journal of Immunology

Volumn 46, Issue 7, 2016, Pages 1783-1796

  Mari, Elisabeth R ^a   Rasouli, Javad ^a   Ciric, Bogoljub ^a   Moore, Jason N ^a   Conejo Garcia, José R ^b   Rajasagi, Naveen ^c   Zhang, Guang Xian ^a   Rabinovich, Gabriel A ^d,e   Rostami, Abdolmohamad ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b WISTAR INSTITUTE   (United States)

^c UNIVERSITY OF TENNESSEE   (United States)

^d CONICET ^*  (Argentina)

^e UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Galectin 1; Tolerance; Tolerogenic DC; Tr1 cell; Treg cell

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; GALECTIN 1; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 6; MESSENGER RNA; MOG 35-55; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; COCULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEMYELINATION; DENDRITIC CELL; DISEASE COURSE; DOWN REGULATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE COUNT; MACROPHAGE; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SPLEEN CELL; SUPERNATANT; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; UPREGULATION;

EID: 84978291025     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201546212     Document Type: Article

References (46)

1. Weiner, H. L., Friedman, A., Miller, A., Khoury, S. J., al-Sabbagh, A., Santos, L., Sayegh, M. et al., Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 1994. 12: 809–837.
2. Miller, A., Zhang, Z. J., Sobel, R. A., al-Sabbagh, A. and Weiner, H. L., Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. VI. Suppression of adoptively transferred disease and differential effects of oral vs. intravenous tolerization. J. Neuroimmunol. 1993. 46: 73–82.
3. Pitkanen, J. and Peterson, P., Autoimmune regulator: from loss of function to autoimmunity. Genes Immun. 2003. 4: 12–21.
4. Puentes, F., Dickhaut, K., Hofstatter, M., Falk, K. and Rotzschke, O., Active suppression induced by repetitive self-epitopes protects against EAE development. PLoS One 2013. 8: e64888.
5. Hilliard, B. A., Kamoun, M., Ventura, E. and Rostami, A., Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: role of regulatory spleen cells. Exp. Mol. Pathol. 2000. 68: 29–37.
6. Li, H., Zhang, G. X., Chen, Y., Xu, H., Fitzgerald, D. C., Zhao, Z. and Rostami, A., CD11c+CD11b+ dendritic cells play an important role in intravenous tolerance and the suppression of experimental autoimmune encephalomyelitis. J. Immunol. 2008. 181: 2483–2493.
7. Hunter, Z., McCarthy, D. P., Yap, W. T., Harp, C. T., Getts, D. R., Shea, L. D. and Miller, S. D., A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease. ACS Nano 2014. 8: 2148–2160.
8. Liblau, R. S., Tisch, R., Shokat, K., Yang, X., Dumont, N., Goodnow, C. C. and McDevitt, H. O., Intravenous injection of soluble antigen induces thymic and peripheral T-cells apoptosis. Proc. Natl. Acad. Sci. USA 1996. 93: 3031–3036.
9. Zhang, G. X., Yu, S., Calida, D., Zhao, Z., Gran, B., Kamoun, M. and Rostami, A., Loss of the surface antigen 3G11 characterizes a distinct population of anergic/regulatory T cells in experimental autoimmune encephalomyelitis. J. Immunol. 2006. 176: 3366–3373.
10. Jiang, Z., Li, H., Fitzgerald, D. C., Zhang, G. X. and Rostami, A., MOG(35-55) i.v suppresses experimental autoimmune encephalomyelitis partially through modulation of Th17 and JAK/STAT pathways. Eur. J. Immunol. 2009. 39: 789–799.
11. Awasthi, A., Carrier, Y., Peron, J. P., Bettelli, E., Kamanaka, M., Flavell, R. A., Kuchroo, V. K. et al., A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 2007. 8: 1380–1389.
12. Vasanthakumar, A. and Kallies, A., IL-27 paves different roads to Tr1. Eur. J. Immunol. 2013. 43: 882–885.
13. Toscano, M. A., Ilarregui, J. M., Bianco, G. A., Campagna, L., Croci, D. O., Salatino, M. and Rabinovich, G. A., Dissecting the pathophysiologic role of endogenous lectins: glycan-binding proteins with cytokine-like activity? Cytokine Growth Factor Rev. 2007. 18: 57–71.
14. Ilarregui, J. M., Croci, D. O., Bianco, G. A., Toscano, M. A., Salatino, M., Vermeulen, M. E., Geffner, J. R. et al., Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat. Immunol. 2009. 10: 981–991.
15. Kopcow, H. D., Rosetti, F., Leung, Y., Allan, D. S., Kutok, J. L. and Strominger, J. L., T cell apoptosis at the maternal-fetal interface in early human pregnancy, involvement of galectin-1. Proc. Natl. Acad. Sci. USA 2008. 105: 18472–18477.
16. Rabinovich, G. A. and Toscano, M. A., Turning ‘sweet’ on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat. Rev. Immunol. 2009. 9: 338–352.
17. van der Leij, J., van den Berg, A., Harms, G., Eschbach, H., Vos, H., Zwiers, P., van Weeghel, R. et al., Strongly enhanced IL-10 production using stable galectin-1 homodimers. Mol. Immunol. 2007. 44: 506–513.
18. Toscano, M. A., Commodaro, A. G., Ilarregui, J. M., Bianco, G. A., Liberman, A., Serra, H. M., Hirabayashi, J. et al., Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses. J. Immunol. 2006. 176: 6323–6332.
19. Wang, J., Lu, Z. H., Gabius, H. J., Rohowsky-Kochan, C., Ledeen, R. W. and Wu, G., Cross-linking of GM1 ganglioside by galectin-1 mediates regulatory T cell activity involving TRPC5 channel activation: possible role in suppressing experimental autoimmune encephalomyelitis. J. Immunol. 2009. 182: 4036–4045.
20. Stowell, S. R., Qian, Y., Karmakar, S., Koyama, N. S., Dias-Baruffi, M., Leffler, H., McEver, R. P. et al., Differential roles of galectin-1 and galectin-3 in regulating leukocyte viability and cytokine secretion. J. Immunol. 2008. 180: 3091–3102.
21. Cedeno-Laurent, F., Opperman, M., Barthel, S. R., Kuchroo, V. K. and Dimitroff, C. J., Galectin-1 triggers an immunoregulatory signature in Th cells functionally defined by IL-10 expression. J. Immunol. 2012. 188: 3127–3137.
22. Toscano, M. A., Bianco, G. A., Ilarregui, J. M., Croci, D. O., Correale, J., Hernandez, J. D., Zwirner, N. W. et al., Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat. Immunol. 2007. 8: 825–834.
23. Garin, M. I., Chu, C. C., Golshayan, D., Cernuda-Morollon, E., Wait, R. and Lechler, R. I., Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. Blood 2007. 109: 2058–2065.
24. Salama, A. D., Chitnis, T., Imitola, J., Ansari, M. J., Akiba, H., Tushima, F., Azuma, M. et al., Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J. Exp. Med. 2003. 198: 71–78.
25. Yao, S., Wang, S., Zhu, Y., Luo, L., Zhu, G., Flies, S., Xu, H. et al., PD-1 on dendritic cells impedes innate immunity against bacterial infection. Blood 2009. 113: 5811–5818.
26. Said, E. A., Dupuy, F. P., Trautmann, L., Zhang, Y., Shi, Y., El-Far, M., Hill, B. J. et al., Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nat. Med. 2010. 16: 452–459.
27. Gagliani, N., Magnani, C. F., Huber, S., Gianolini, M. E., Pala, M., Licona-Limon, P., Guo, B. et al., Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat. Med. 2013. 19: 739–746.
28. Yamazaki, S., Iyoda, T., Tarbell, K., Olson, K., Velinzon, K., Inaba, K. and Steinman, R. M., Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 2003. 198: 235–247.
29. Maldonado-Lopez, R., De Smedt, T., Pajak, B., Heirman, C., Thielemans, K., Leo, O., Urbain, J. et al., Role of CD8alpha+ and CD8alpha- dendritic cells in the induction of primary immune responses in vivo. J. Leukoc. Biol. 1999. 66: 242–246.
30. Dillon, S., Agrawal, S., Banerjee, K., Letterio, J., Denning, T. L., Oswald-Richter, K., Kasprowicz, D. J. et al., Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J. Clin. Invest. 2006. 116: 916–928.
31. Mascanfroni, I. D., Yeste, A., Vieira, S. M., Burns, E. J., Patel, B., Sloma, I., Wu, Y. et al., IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39. Nat. Immunol. 2013. 14: 1054–1063.
32. Zhang, G. X., Gran, B., Yu, S., Li, J., Siglienti, I., Chen, X., Kamoun, M. et al., Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system. J. Immunol. 2003. 170: 2153–2160.
33. Norling, L. V., Sampaio, A. L., Cooper, D. and Perretti, M., Inhibitory control of endothelial galectin-1 on in vitro and in vivo lymphocyte trafficking. FASEB J. 2008. 22: 682–690.
34. Rabinovich, G. A., Sotomayor, C. E., Riera, C. M., Bianco, I. and Correa, S. G., Evidence of a role for galectin-1 in acute inflammation. Eur. J. Immunol. 2000. 30: 1331–1339.
35. Starossom, S. C., Mascanfroni, I. D., Imitola, J., Cao, L., Raddassi, K., Hernandez, S. F., Bassil, R. et al., Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration. Immunity 2012. 37: 249–263.
36. Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M. and Weaver, C. T., Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005. 6: 1123–1132.
37. Haak, S., Croxford, A. L., Kreymborg, K., Heppner, F. L., Pouly, S., Becher, B. and Waisman, A., IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J. Clin. Invest. 2009. 119: 61–69.
38. Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K. et al., IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006. 177: 566–573.
39. Kroenke, M. A., Carlson, T. J., Andjelkovic, A. V. and Segal, B. M., IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 2008. 205: 1535–1541.
40. Blaser, C., Kaufmann, M., Muller, C., Zimmermann, C., Wells, V., Mallucci, L. and Pircher, H., Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells. Eur. J. Immunol. 1998. 28: 2311–2319.
41. Greter, M., Heppner, F. L., Lemos, M. P., Odermatt, B. M., Goebels, N., Laufer, T., Noelle, R. J. et al., Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 2005. 11: 328–334.
42. Pulendran, B., Smith, J. L., Caspary, G., Brasel, K., Pettit, D., Maraskovsky, E. and Maliszewski, C. R., Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. USA 1999. 96: 1036–1041.
43. Morelli, A. E. and Thomson, A. W., Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 2007. 7: 610–621.
44. Fitzgerald, D. C., Zhang, G. X., El-Behi, M., Fonseca-Kelly, Z., Li, H., Yu, S., Saris, C. J. et al., Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 2007. 8: 1372–1379.
45. Darrasse-Jeze, G., Deroubaix, S., Mouquet, H., Victora, G. D., Eisenreich, T., Yao, K. H., Masilamani, R. F. et al., Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J. Exp. Med. 2009. 206: 1853–1862.
46. Poirier, F. and Robertson, E. J., Normal development of mice carrying a null mutation in the gene encoding the L14 S-type lectin. Development 1993. 119: 1229–1236.